DFTX · Forms 3, 4, 5
Insider trades at Definium Therapeutics, Inc.
5 insiders sold $2.3M of Definium Therapeutics, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Definium Therapeutics, Inc. (DFTX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Daniel Karlin | Chief Medical Officer | Sell | 10,853 | $36.57 | $397K | Form 4 | |
| Robert Barrow | Chief Executive Officer | Sell | 31,550 | $36.57 | $1.2M | Form 4 | |
| Matthew T. Wiley | Chief Commercial Officer | Sell | 3,097 | $36.57 | $113K | Form 4 | |
| Mark Sullivan | Chief Legal Officer | Sell | 14,051 | $36.57 | $514K | Form 4 | |
| Brandi Roberts | Chief Financial Officer | Sell | 3,377 | $36.57 | $123K | Form 4 | |
| Carol A Vallone | Director | Option exercise | 1,086 | $35.52 | $39K | Form 4 | |
| Andreas Krebs | Director | Option exercise | 1,629 | $35.52 | $58K | Form 4 | |
| Daniel Karlin | Chief Medical Officer | Award | 200,000 | Form 4 | |||
| Matthew T. Wiley | Chief Commercial Officer | Award | 125,000 | Form 4 | |||
| Mark Sullivan | Chief Legal Officer | Award | 125,000 | Form 4 | |||
| Brandi Roberts | Chief Financial Officer | Award | 125,000 | Form 4 | |||
| Robert Barrow | Chief Executive Officer | Award | 750,000 | Form 4 | |||
| Robert Barrow | Chief Executive Officer | Sell | 19,023 | $37.94 | $722K | Form 4 | |
| Robert Barrow | Chief Executive Officer | Award | 40,000 | Form 4 | |||
| Robert Barrow | Chief Executive Officer | Award | 375,000 | Form 4 | |||
| Daniel Karlin | Chief Medical Officer | Award | 100,000 | Form 4 | |||
| Mark Sullivan | Chief Legal Officer | Award | 62,500 | Form 4 | |||
| Matthew T. Wiley | Chief Commercial Officer | Award | 62,500 | Form 4 | |||
| Brandi Roberts | Chief Financial Officer | Award | 62,500 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.